Grauer & Weil India financials

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast closeFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
3,722————
268268177173109
8.38.37.421.718.5
3,463————
1,1781,1781,1281,054976
—+4.5%+6.9%+8.0%—
197197188188154
16.7%16.7%16.7%17.8%15.8%
172172166167134
167167157144112
14.2%14.2%13.9%13.7%11.5%
₹3.69₹3.69₹3.46₹3.18₹2.47
—+6.5%+9.0%+28.7%—
154154145158113
−49.2−49.2−43.1−31.5−14.2
10510510212698.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GRAUWEIL₹82.12

Grauer & Weil India Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASINDOKEMJYOTIRESKANCHIMcap ₹3,722 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
Market Capitalization————3,722.3
- Cash, Equiv & ST Investments108.7173.3176.5267.9267.9
+ Total Debt18.521.77.48.38.3
Enterprise Value————3,462.7
Revenue976.11,054.31,127.61,178.41,178.4
Growth %, YoY—+8.0+6.9+4.5—
EBITDA154.0187.8188.3196.6196.6
Margin %15.7817.8116.7016.6816.68
EBIT134.4167.1166.0172.5172.5
Net Income111.9144.0157.0167.3167.3
Margin %11.4613.6613.9214.1914.19
EPS, Adj (current shares)2.473.183.463.693.69
Growth %, YoY—+28.7+9.0+6.5—
Cash from Operations112.9157.9144.9153.7153.7
Capital Expenditures-14.2-31.5-43.1-49.2-49.2
Free Cash Flow98.8126.4101.9104.6104.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.

Grauer & Weil India financials and key ratios

Figures from the company's filings with NSE

In FY26 its consolidated net profit was ₹167 crore on revenue of ₹1,178 crore.

Grauer & Weil India at a glance · consolidated

Free cash flow (FY26)
₹105 Cr+2.6% vs FY25
EPS (FY26)
₹3.69

Questions

What is the Grauer & Weil India EPS?

Grauer & Weil India's basic earnings per share (EPS) were ₹3.69 in FY26, against ₹3.46 in FY25.

What is the Grauer & Weil India dividend in 2026 and its record date?

In 2026, Grauer & Weil India has declared one dividend: ₹0.50 with record date 10 September 2026.

Grauer & Weil India vs Amal: how do they compare?

In FY26, Grauer & Weil India earned net profit of ₹167 crore on revenue of ₹1,178 crore, against ₹4.5 crore on ₹84.9 crore for Amal. Grauer & Weil India's operating margin was 14.6% (Amal 7.5%).

What is the Grauer & Weil India free cash flow?

In FY26, Grauer & Weil India generated ₹154 crore of cash from operations and spent ₹49.2 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹105 crore. In FY25 it was ₹102 crore.

What is the Grauer & Weil India revenue and profit in FY26?

In FY26 (April 2025–March 2026), Grauer & Weil India's consolidated net profit was ₹167 crore, up 6.5% from ₹157 crore in FY25, on revenue from operations of ₹1,178 crore (up 4.5%). Over three years, from FY23, net profit was up 49.5%.

How does Grauer & Weil India compare with its peers?

On FY26 consolidated figures, against Amal and Chemcrux Enterprises: Grauer & Weil India's operating margin of 14.6% is the highest of the three (Amal 7.5%, Chemcrux Enterprises 6.6%; peer average 7.0%); its revenue growth over three years of 6.5% a year is the second highest of the three (Amal 29.4% a year, Chemcrux Enterprises −4.6% a year; peer average 12.4% a year).

Where do these Grauer & Weil India figures come from?

From Grauer & Weil India's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.